Pomanda estimates the enterprise value of ATLAS PHARMA CONSULTING LIMITED at £271.9k based on a Turnover of £748.9k and 0.36x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ATLAS PHARMA CONSULTING LIMITED at £0 based on an EBITDA of £-907 and a 2.6x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ATLAS PHARMA CONSULTING LIMITED at £0 based on Net Assets of £-235.5k and 2.37x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Atlas Pharma Consulting LimitedOverview
Atlas Pharma Consulting Limited is a live company located in london, EC2R 6AY with a Companies House number of 12799003. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in August 2020, it's largest shareholder is
this is avalon group limited
with a 100% stake. Atlas Pharma Consulting Limited is a young,
small sized company, Pomanda has estimated its turnover at
£748.9k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Atlas Pharma Consulting Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
2 Strong
1 Regular
6 Weak
Size
annual sales of £748.9k, make it smaller than the average company (£4.8m)
£748.9k - Atlas Pharma Consulting Limited
£4.8m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Atlas Pharma Consulting Limited
- - Industry AVG
Production
with a gross margin of 17%, this company has a higher cost of product (38.2%)
17% - Atlas Pharma Consulting Limited
38.2% - Industry AVG
Profitability
an operating margin of -0.1% make it less profitable than the average company (5.7%)
-0.1% - Atlas Pharma Consulting Limited
5.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (27)
2 - Atlas Pharma Consulting Limited
27 - Industry AVG
Pay Structure
on an average salary of £54k, the company has an equivalent pay structure (£54k)
£54k - Atlas Pharma Consulting Limited
£54k - Industry AVG
Efficiency
resulting in sales per employee of £374.5k, this is more efficient (£170.9k)
£374.5k - Atlas Pharma Consulting Limited
£170.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Atlas Pharma Consulting Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 139 days, this is slower than average (32 days)
139 days - Atlas Pharma Consulting Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Atlas Pharma Consulting Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (22 weeks)
0 weeks - Atlas Pharma Consulting Limited
22 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 11874.1%, this is a higher level of debt than the average (62.6%)
11874.1% - Atlas Pharma Consulting Limited
62.6% - Industry AVG
ATLAS PHARMA CONSULTING LIMITED financials
EXPORT
Atlas Pharma Consulting Limited's latest turnover from December 2023 is estimated at £748.9 thousand and the company has net assets of -£235.5 thousand. According to their latest financial statements, we estimate that Atlas Pharma Consulting Limited has 2 employees and maintains cash reserves of £2 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Turnover
748,905
789,217
372,430
Other Income Or Grants
Cost Of Sales
621,827
654,584
314,058
Gross Profit
127,078
134,633
58,371
Admin Expenses
127,985
63,015
353,793
Operating Profit
-907
71,618
-295,422
Interest Payable
Interest Receivable
907
1,102
38
Pre-Tax Profit
72,720
-295,384
Tax
-13,817
Profit After Tax
58,903
-295,384
Dividends Paid
Retained Profit
58,903
-295,384
Employee Costs
108,009
153,949
48,760
Number Of Employees
2
3
1
EBITDA*
-907
71,618
-295,051
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Tangible Assets
844
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
844
Stock & work in progress
Trade Debtors
31,000
Group Debtors
Misc Debtors
Cash
2,000
32,561
30,424
misc current assets
total current assets
2,000
32,561
61,424
total assets
2,000
32,561
62,268
Bank overdraft
Bank loan
Trade Creditors
237,481
268,042
356,652
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
237,481
268,042
356,652
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
237,481
268,042
356,652
net assets
-235,481
-235,481
-294,384
total shareholders funds
-235,481
-235,481
-294,384
Dec 2023
Dec 2022
Dec 2021
Operating Activities
Operating Profit
-907
71,618
-295,422
Depreciation
371
Amortisation
Tax
-13,817
Stock
Debtors
-31,000
31,000
Creditors
-30,561
-88,610
356,652
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
-31,468
191
30,601
Investing Activities
capital expenditure
844
-1,215
Change in Investments
cash flow from investments
844
-1,215
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1,000
interest
907
1,102
38
cash flow from financing
907
1,102
1,038
cash and cash equivalents
cash
-30,561
2,137
30,424
overdraft
change in cash
-30,561
2,137
30,424
atlas pharma consulting limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for atlas pharma consulting limited. Get real-time insights into atlas pharma consulting limited's credit score, group structure and payment trends.
Perform a competitor analysis for atlas pharma consulting limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other small companies, companies in EC2R area or any other competitors across 12 key performance metrics.
atlas pharma consulting limited Ownership
ATLAS PHARMA CONSULTING LIMITED group structure
Atlas Pharma Consulting Limited has no subsidiary companies.
The sole shareholder of Atlas Pharma Consulting Limited is This Is Avalon Group Limited.
this is avalon group limited
100%
atlas pharma consulting limited directors
Atlas Pharma Consulting Limited currently has 4 directors.
The longest serving directors include
Mr Daniel Zaret (Aug 2022) and
Mr Daniel Zaret (Aug 2022).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to atlas pharma consulting limited. Currently there are 0 open charges and 1 have been satisfied in the past.
atlas pharma consulting limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ATLAS PHARMA CONSULTING LIMITED. This can take several minutes, an email will notify you when this has completed.
atlas pharma consulting limitedCompanies House Filings - See Documents
